一、项目名称：原料药及医药中间体生产加工项目

二、项目背景

清浦区西安路工业园，紧靠淮安市老工业基地，规划面积10平方公里，目前已建成5平方公里，水、电、路、气、讯配套齐全。医药产业是园区的四大主导产业之一，已入住的江苏天士力帝益药业有限公司由天士力集团投资建设，占地200亩，是集研发、生产、营销整条产业链高科技制药企业。年产变性淀粉5万吨、肝泰乐600万吨，是全球最大的肝泰乐生产基地。浙江台州投资兴建的诚意药业医药中间体项目年产值亿元以上，欢迎有识之士来我区投资兴建医药加工项目。

三、建设内容：原料药及医药中间体

四、投资规模：1亿元以上

五、建设地点：清浦工业新区

六、项目提出单位：清浦工业园

29.Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates Producing and Processing Project

1.Project name：Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates Producing and Processing Project

2. Project background

Xi’an Road Industry Park in Qingpu District, 10 square kilometers in area for investment,is close to Huaian city’s old industrial base. At present, 5 square kilometers of the industrial zone has been finished with supporting system like water, electricity, traffic, gas, communication devices. Pharmaceutical industry is one of the four dominant industries in the park. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., as the company in the park, is invested by Tasly Group and occupies 200 mu in area. It is a high-tech pharmaceutical enterprise undertaking medicine research, manufacturing and marketing with an annual output of 50 thousand tons of Modified Starch and six million tons of Glucurolactone. It is the biggest production base of Glucurolactone in the world. The pharmaceutical intermediates project of Jiangsu Chengyi Pharmaceutical Co., invested by Taizhou capital of Zhejiang province, can get an annual output value of RMB 100 million or more. Welcome to invest pharmaceutical processing items in the Park.

3. Project content:Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates

4. Investment scale:RMB 100 million or more

5. Construction location:Qingpu New Industry Zone

6. Project presenter:Qingpu Industry Park